Table 2.

Outcomes of general practice virtual clinics 2018/2019

General practice ID number*	DM number on register†	% excluded diabetes review‡	Patients reviewed in visit to practice	Treatment optimal no change needed	Type 2 remission diet requested	Intense lifestyle advice advised	Insulin initiation	SGLT2 inhibitor or GLP1 agonist	Monogenic diabetes diagnosed	Libre issued	Intractable/ terminal care the priority	Psych referral advised	Other medical specialty referral
1	850	16	30	2	1	5	7	1	2	2	–	3	7
2	190	8.6	9	3	–	1	1	1	–	1	2	–	–
3	950	11.5	11	2	–	–	–	1	–	–	1	–	–
4	510	21.7	12	3	–	4	2	1	–	–	–	1	–
5	432	13.7	5	–	1	1	–	1	–	–	–	–	2
6	1075	20.6	5	–	–			3	–	1	1	–	–
7	590	13.4	18	7	–	2	4	2	–	1	1	–	1
8	145	10.6	6	–	1		2	1	1	–	–	–	1
9	1057	16.4	9	1		4	1	1	–	–	1	–	1
10	840	16.1	11	1	1	1	2	–	2	–	2	1	–
11	280	8.1	14	3		7	2	1	–	–	–	1	–
12	685	17.3	10	2	1	2	3	1	–	–	–	–	1
13	568	20	3	–	–	1	–	1	–	–	–	1
14	795	17.8	13	4	–		2	2	1	1	1	1	1
15	295	17.4	9	1	1	3	1	1	1	–	–	–	1
16	345	12.8	3	1	–	–	2	–	–	–	–	–	–
17	420	16	9	2	1	3	–	1	1	–	–	1	–
Total	10 616	15.2	175	32	7	34	29	19	8	6	9	9	15

*Each practice was given a sequential number 1–17.

†DM number means number of people with diabetes on each general practice QOF register.

‡In the NHS in England community physicians (general practitioners) report annual reviews of patients with long-term conditions including diabetes. Patients may be excluded from this QOF for a variety of reasons.

GLP1, glucagon-like peptide-1; GP, general practitioner; NHS, National Health Service; QOF, quality outcomes framework; SGLT2, sodium-glucose cotransporter-2 inhibitor.